Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

Optimising Renal Outcome in Myeloma Renal Failure

NCT02424851

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations
  • Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom
  • Heartlands Hospitals Birmingham, United Kingdom
  • Kent & Canterbury Hospital Canterbury, United Kingdom
  • St Helier Hospital Epsom, United Kingdom
View Trial Details
Completed

Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory or Relapsed and Refractory Multiple Myeloma

NCT01712789

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Medical University of Graz Graz, Austria
  • Medizinische Universitat Innsbruck Innsbruck, Austria
  • Wilhelminenspital Vienna Vienna, Austria
  • Medical University of Vienna Vienna, Austria
View all 112 locations
View Trial Details
Completed

Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma

NCT01962792

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View all 17 locations
View Trial Details
Completed

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

NCT01109004

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCSD Medical Center La Jolla, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 54 locations
View Trial Details
Completed

A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma

NCT01421186

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I Vienna, Austria
  • Charité - Universitätsmedizin Berlin, CBF: Campus Benjamin Franklin, CC 14: Tumormedizin, Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie Berlin, Germany
  • Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Germany
  • Medizinische Klinik 5 - Hämatologie und Internist. Onkologie, Universitätsklinikum Erlangen Erlangen, Germany
View Trial Details

Related conditions